EN HU

Fehér Ádám

Fehér Ádám

Publication list

Uploaded publications:
13
Publications in DEA:
13
OA:
12
Date range:
2020-2025
2025
1.
Óvári, J., Kovács, Z. M., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Domingos, G. J., Fehér, Á., Varga, Z., Szentandrássy, N.: Delavirdine modifies action potential configuration via inhibition of IKr and Ito in canine ventricular myocytes.
Biomed. Pharmacother. 186, 1-13, (article identifier: 117994), 2025.
Journal metrics:
D1 Medicine (miscellaneous) (2024)
D1 Pharmacology (2024)
2024
2.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: Correction: Kovács et al. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
Pharmaceuticals. 17 (9), 1-2, (article identifier: 1137), 2024.
3.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Correction to "Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening".
J. Chem Inf. Model. 64 (24), 9651, 2024.
4.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Identification of a Novel Structural Class of Hv1 Inhibitors by Structure-Based Virtual Screening.
J. Chem Inf. Model. 64 (12), 4850-4862, 2024.
Journal metrics:
Q1 Chemical Engineering (miscellaneous)
Q1 Chemistry (miscellaneous)
Q1 Computer Science Applications
D1 Library and Information Sciences
2023
5.
Szántó, G. T., Fehér, Á., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K., Lányi, Á., Panyi, G., Varga, Z.: 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel.
Pharmaceuticals (Basel). 16 (5), 1-15, (article identifier: 656), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
6.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr.
Pharmaceuticals (Basel). 16 (4), 488, (article identifier: 488), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
7.
Nemes, B. Á., László, S., Zsidó, Z. B., Hetényi, C., Fehér, Á., Papp, F., Varga, Z., Szőke, É., Sándor, Z., Pintér, E.: Elucidation of the binding mode of organic polysulfides on the human TRPA1 receptor.
Front. Physiol. 14, 1-16, (article identifier: 1180896), 2023.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
2022
8.
Fehér, Á., Pócsi, M., Papp, F., Szántó, G. T., Csóti, Á., Fejes, Z., Nagy, B. J., Nemes, B. Á., Varga, Z.: Functional Voltage-Gated Sodium Channels Are Present in the Human B Cell Membrane.
Cells. 11 (7), 1-15, (article identifier: 1225), 2022.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
9.
Bátai, I. Z., Dombi, Á., Borbély, É., Fehér, Á., Papp, F., Varga, Z., Mócsai, A., Helyes, Z., Pintér, E., Pozsgai, G.: Investigation of the Role of the TRPA1 Ion Channel in Conveying the Effect of Dimethyl Trisulfide on Vascular and Histological Changes in Serum-Transfer Arthritis.
Pharmaceuticals (Basel). 15 (6), 1-15, (article identifier: 671), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
10.
Fehér, Á., Pethő, Z., Szántó, G. T., Klekner, Á., Tajti, G., Batta, G., Hortobágyi, T., Varga, Z., Schwab, A., Panyi, G.: Mapping the functional expression of auxiliary subunits of KCa1.1 in glioblastoma.
Sci. Rep. 12 (1), 1-14, (article identifier: 22023), 2022.
Journal metrics:
D1 Multidisciplinary
11.
Papp, F., Toombes, G. E. S., Pethő, Z., Bagosi, A., Fehér, Á., Almássy, J., Borrego, J., Kuki, Á., Kéki, S., Panyi, G., Varga, Z.: Multiple mechanisms contribute to fluorometry signals from the voltage-gated proton channel.
Commun Biol. 5 (1), 1131, (article identifier: 1131), 2022.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2021
12.
Borrego, J., Fehér, Á., Jost, N., Panyi, G., Varga, Z., Papp, F.: Peptide Inhibitors of Kv1.5: an Option for the Treatment of Atrial Fibrillation.
Pharmaceuticals (Basel). 14 (12), 1-21, (article identifier: 1303), 2021.
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
2020
13.
Fehér, Á.: A sejtciklus hatása a BK csatorna fenotípusára glioblasztóma sejteken.
OxIPO. 1, 9-22, 2020.
DEENK University of Debrecen
© 2012 University of Debrecen